Drreddys Laboratories | RDY - Operating Expenses


Drreddys Laboratories reported INR72.94B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
ANI Pharmaceuticals USD 217.93M 287.88M Dec/2025
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Canopy Growth CAD 87.2M 6.22M Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Drreddys Laboratories INR 72.94B 4.33B Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Novartis USD 9.8B 61M Dec/2025
Pacira USD 193.68M 27.32M Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 200.95M 6.51M Dec/2025
Richter Gedeon HUF 151.11B 20.72B Sep/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Supernus Pharmaceuticals USD 197.75M 54.54M Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025